Our overall hedge fund sentiment score for UBX is 33.5. (NASDAQ:UBX) is not the least popular stock in this group but hedge fund interest is still below average. On the other hand SWK Holdings Corporation (NASDAQ: SWKH) is the least popular one with only 3 bullish hedge fund positions. Tilly's Inc (NYSE: TLYS) is the most popular stock in this table. That figure was $2 million in UBX's case.
View table here if you experience formatting issues.Īs you can see these stocks had an average of 9.3 hedge funds with bullish positions and the average amount invested in these stocks was $35 million. This group of stocks' market valuations resemble UBX's market valuation. (NASDAQ: OPTN), SWK Holdings Corporation (NASDAQ: SWKH), Contango Oil & Gas Company (NYSE: MCF), Nabors Industries Ltd. We will take a look at Moneygram International Inc (NASDAQ: MGI), Tilly's Inc (NYSE: TLYS), OptiNose, Inc. Let's now review hedge fund activity in other stocks similar to Unity Biotechnology, Inc. These transactions are important to note, as aggregate hedge fund interest fell by 2 funds in the third quarter. Renaissance Technologies, also sold off its stock, about $2.4 million worth. Intriguingly, Israel Englander's Millennium Management cut the biggest position of all the hedgies monitored by Insider Monkey, worth close to $4.6 million in stock. (NASDAQ:UBX) has witnessed a decline in interest from the aggregate hedge fund industry, it's easy to see that there exists a select few funds that decided to sell off their entire stakes in the third quarter. Judging by the fact that Unity Biotechnology, Inc. Algert Global is also relatively very bullish on the stock, earmarking 0.06 percent of its 13F equity portfolio to UBX.
(NASDAQ:UBX), around 0.07% of its 13F portfolio. In terms of the portfolio weights assigned to each position EcoR1 Capital allocated the biggest weight to Unity Biotechnology, Inc. Other peers that are bullish include Ken Griffin's Citadel Investment Group, Peter Algert's Algert Global and Peter Muller's PDT Partners. On EcoR1 Capital's heels is Arrowstreet Capital, led by Peter Rathjens, Bruce Clarke and John Campbell, holding a $0.4 million position less than 0.1%% of its 13F portfolio is allocated to the stock. EcoR1 Capital has a $1 million position in the stock, comprising 0.1% of its 13F portfolio. Our calculations also showed that UBX isn't among the 30 most popular stocks among hedge funds (click for Q3 rankings and see the video for a quick look at the top 5 stocks).Īccording to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, EcoR1 Capital, managed by Oleg Nodelman, holds the most valuable position in Unity Biotechnology, Inc. There were 7 hedge funds in our database with UBX holdings at the end of June. UBX investors should pay attention to a decrease in activity from the world's largest hedge funds in recent months. The all time high for this statistics is 7. (NASDAQ: UBX) was in 5 hedge funds' portfolios at the end of September. In this article, we analyze how these elite funds and prominent investors traded Unity Biotechnology, Inc. We at Insider Monkey have made an extensive database of more than 817 of those established hedge funds and famous value investors' filings.
The latest round of 13F filings disclosed the funds' positions on September 30th, about a month before the elections. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
0 kommentar(er)
